293 related articles for article (PubMed ID: 11445516)
1. Oral succimer decreases the gastrointestinal absorption of lead in juvenile monkeys.
Cremin JD; Luck ML; Laughlin NK; Smith DR
Environ Health Perspect; 2001 Jun; 109(6):613-9. PubMed ID: 11445516
[TBL] [Abstract][Full Text] [Related]
2. Succimer and the reduction of tissue lead in juvenile monkeys.
Smith DR; Woolard D; Luck ML; Laughlin NK
Toxicol Appl Pharmacol; 2000 Aug; 166(3):230-40. PubMed ID: 10906287
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of succimer chelation for reducing brain lead in a primate model of human lead exposure.
Cremin JD; Luck ML; Laughlin NK; Smith DR
Toxicol Appl Pharmacol; 1999 Dec; 161(3):283-93. PubMed ID: 10620486
[TBL] [Abstract][Full Text] [Related]
4. Succimer and the urinary excretion of essential elements in a primate model of childhood lead exposure.
Smith DR; Calacsan C; Woolard D; Luck M; Cremin J; Laughlin NK
Toxicol Sci; 2000 Apr; 54(2):473-80. PubMed ID: 10774830
[TBL] [Abstract][Full Text] [Related]
5. The effects of succimer on the absorption of lead in adults determined by using the stable isotope 204Pb.
Smith DR; Markowitz ME; Crick J; Rosen JF; Flegal AR
Environ Res; 1994 Oct; 67(1):39-53. PubMed ID: 7925193
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of succimer chelation for reducing brain Pb levels in a rodent model.
Smith D; Bayer L; Strupp BJ
Environ Res; 1998 Aug; 78(2):168-76. PubMed ID: 9719621
[TBL] [Abstract][Full Text] [Related]
7. Influence of 2,3-dimercaptosuccinic acid on gastrointestinal lead absorption and whole-body lead retention.
Kapoor SC; Wielopolski L; Graziano JH; LoIacono NJ
Toxicol Appl Pharmacol; 1989 Mar; 97(3):525-9. PubMed ID: 2558428
[TBL] [Abstract][Full Text] [Related]
8. The effects of elevated blood lead levels and succimer chelation therapy on physical growth in developing rhesus monkeys.
Lasky RE; Laughlin NK; Luck ML
Environ Res; 2001 Sep; 87(1):21-30. PubMed ID: 11534961
[TBL] [Abstract][Full Text] [Related]
9. Effect of meso-2,3-dimercaptosuccinic acid on urinary lead excretion in exposed men.
Torres-Alanís O; Garza-Ocañas L; Piñeyro-López A
Hum Exp Toxicol; 2002 Nov; 21(11):573-7. PubMed ID: 12507251
[TBL] [Abstract][Full Text] [Related]
10. Use of oral dimercaptosuccinic acid (succimer) in adult patients with inorganic lead poisoning.
Bradberry S; Sheehan T; Vale A
QJM; 2009 Oct; 102(10):721-32. PubMed ID: 19700440
[TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of meso-2,3-dimercaptosuccinic acid (DMSA) in children with elevated blood lead concentrations.
Chisolm JJ
J Toxicol Clin Toxicol; 2000; 38(4):365-75. PubMed ID: 10930052
[TBL] [Abstract][Full Text] [Related]
12. Effect of chelation with meso-dimercaptosuccinic acid (DMSA) before and after the appearance of lead-induced neurotoxicity in the rat.
Gong Z; Evans HL
Toxicol Appl Pharmacol; 1997 Jun; 144(2):205-14. PubMed ID: 9194404
[TBL] [Abstract][Full Text] [Related]
13. Effect of chelation therapy on the neuropsychological and behavioral development of lead-exposed children after school entry.
Dietrich KN; Ware JH; Salganik M; Radcliffe J; Rogan WJ; Rhoads GG; Fay ME; Davoli CT; Denckla MB; Bornschein RL; Schwarz D; Dockery DW; Adubato S; Jones RL;
Pediatrics; 2004 Jul; 114(1):19-26. PubMed ID: 15231903
[TBL] [Abstract][Full Text] [Related]
14. Dimercaptosuccinic acid (succimer; DMSA) in inorganic lead poisoning.
Bradberry S; Vale A
Clin Toxicol (Phila); 2009 Aug; 47(7):617-31. PubMed ID: 19663612
[TBL] [Abstract][Full Text] [Related]
15. Controlled study of meso-2,3-dimercaptosuccinic acid for the management of childhood lead intoxication.
Graziano JH; Lolacono NJ; Moulton T; Mitchell ME; Slavkovich V; Zarate C
J Pediatr; 1992 Jan; 120(1):133-9. PubMed ID: 1309865
[TBL] [Abstract][Full Text] [Related]
16. Succimer treatment and calcium supplementation reduce tissue lead in suckling rats.
Marija Varnai V; Piasek M; Blanusa M; Matek Sarić M; Juresa D; Kostial K
J Appl Toxicol; 2004; 24(2):123-8. PubMed ID: 15052607
[TBL] [Abstract][Full Text] [Related]
17. Description of 3,180 courses of chelation with dimercaptosuccinic acid in children ≤ 5 y with severe lead poisoning in Zamfara, Northern Nigeria: a retrospective analysis of programme data.
Thurtle N; Greig J; Cooney L; Amitai Y; Ariti C; Brown MJ; Kosnett MJ; Moussally K; Sani-Gwarzo N; Akpan H; Shanks L; Dargan PI
PLoS Med; 2014 Oct; 11(10):e1001739. PubMed ID: 25291378
[TBL] [Abstract][Full Text] [Related]
18. Use of orally administered succimer (meso-2,3-dimercaptosuccinic acid) for treatment of lead poisoning in dogs.
Ramsey DT; Casteel SW; Faggella AM; Chastain CB; Nunn JW; Schaeffer DJ
J Am Vet Med Assoc; 1996 Feb; 208(3):371-5. PubMed ID: 8575967
[TBL] [Abstract][Full Text] [Related]
19. [Effects of chelation therapy with succimer in young rabbits of moderate lead poisoning].
Yu GY; Yan CH; Yu XG; Zuo Y; Zou XY; Xu J; Wu SH; Shen XM
Zhonghua Yu Fang Yi Xue Za Zhi; 2009 Jan; 43(1):8-13. PubMed ID: 19534872
[TBL] [Abstract][Full Text] [Related]
20. Effect of L-arginine, dimercaptosuccinic acid (DMSA) and the association of L-arginine and DMSA on tissue lead mobilization and blood pressure level in plumbism.
Malvezzi CK; Moreira EG; Vassilieff I; Vassilieff VS; Cordellini S
Braz J Med Biol Res; 2001 Oct; 34(10):1341-6. PubMed ID: 11593311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
